Interestingly, we found that by blocking the expressions of Sirt1 and AMPK, the therapeutic efficacy of PAP was altered, suggesting that AMPK and Sirt1 play critical roles in the PAP-relieved depression. Here, SIRT1 is linked to depressive symptom measurement.